Any feedback?
Literature summary extracted from
- Engineering of a hybrid biotransformation system for cytochrome P450sca-2 in Escherichia coli (2013), Biotechnol. J., 8, 785-793.
Application
| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 1.18.1.5 | synthesis | stereoselective production of pravastatin from avastatin by Escherichia coli co-expressing putidaredoxin reductase and putidaredoxin from Pseudomonas putida with cytochrome P450 105A3 from Streptomyces carbophilus. Improved active P450 expression leads to 4.1fold increase in pravastatin yield | Pseudomonas putida |
Cloned(Commentary)
| EC Number | Cloned (Comment) | Organism |
|---|---|---|
| 1.18.1.5 | - |
Pseudomonas putida |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 1.18.1.5 | Pseudomonas putida | - |
- |
- |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
